139 related articles for article (PubMed ID: 10233373)
1. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
[TBL] [Abstract][Full Text] [Related]
3. [Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].
Paloma MJ; Páramo JA; Rifón J; Rocha E
Sangre (Barc); 1992 Dec; 37(6):435-8. PubMed ID: 1293794
[TBL] [Abstract][Full Text] [Related]
4. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
[TBL] [Abstract][Full Text] [Related]
5. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
Hermida J; Montes R; Páramo JA; Rocha E
J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
[TBL] [Abstract][Full Text] [Related]
7. Effect of DDAVP on endotoxin-induced intravascular coagulation in rabbits.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1992 Sep; 68(3):306-9. PubMed ID: 1440497
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
[TBL] [Abstract][Full Text] [Related]
9. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
[TBL] [Abstract][Full Text] [Related]
10. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
11. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
Gómez C; Páramo JA; Colucci M; Rocha E
Thromb Haemost; 1989 Sep; 62(2):694-8. PubMed ID: 2683190
[TBL] [Abstract][Full Text] [Related]
12. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
[TBL] [Abstract][Full Text] [Related]
13. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
[TBL] [Abstract][Full Text] [Related]
14. Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1.
Montes R; Declerck PJ; Calvo A; Montes M; Hermida J; Muñoz MC; Rocha E
Thromb Haemost; 2000 Jul; 84(1):65-70. PubMed ID: 10928472
[TBL] [Abstract][Full Text] [Related]
15. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
16. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits.
Zawilska K; Zozulinska M; Turowiecka Z; Blahut M; Drobnik L; Vinazzer H
Thromb Res; 1993 Feb; 69(3):315-20. PubMed ID: 8475480
[TBL] [Abstract][Full Text] [Related]
17. PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activity.
Krishnamurti C; Keyt B; Maglasang P; Alving BM
Blood; 1996 Jan; 87(1):14-9. PubMed ID: 8547635
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
Francis RB; Seyfert U
J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
[TBL] [Abstract][Full Text] [Related]
19. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
20. The effect of anticoagulation with subcutaneously delivered polyethylene glycol conjugated hirudin and recombinant tissue plasminogen activator on recurrent stenosis in the rabbit double-balloon injury model.
Alexander B; Burnand KG; Lattimer CL; Humphries J; Gaffney PJ; Eastham D; Smith A
Thromb Res; 2004; 113(2):155-61. PubMed ID: 15115671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
